Highlights
- Market Cap
- $113.42M
- Enterprise Value
- $264.52M
- EPS (TTM)
- -$0.07
- Total Revenue (TTM)
- $300.82M
- Gross Profit (TTM)
- $196.33M
- EBITDA (TTM)
- $32.02M
- Year Range
- $0.76 - $2.69
- Target Price
- $2.55
- ROA (TTM)
- -1.90%
- ROE (TTM)
- -15.57%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in The Beauty Health Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
The Beauty Health Company (SKIN) has returned -35.97% so far this year and -33.58% over the past 12 months.
The Beauty Health Company
- 1D
- 8.52%
- 1M
- -14.42%
- YTD
- -35.97%
- 6M
- -55.28%
- 1Y
- -33.58%
- 3Y*
- -58.70%
- 5Y*
- -39.22%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Nov 24, 2020, SKIN's average daily return is -0.02%, while the average monthly return is -1.80%.
Historically, 43% of months were positive and 57% were negative. The best month was May 2025 with a return of +64.4%, while the worst month was Jan 2022 at -41.2%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 6 months.
On a daily basis, SKIN closed higher 46% of trading days. The best single day was May 9, 2025 with a return of +50.8%, while the worst single day was Nov 14, 2023 at -64.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.91% | -30.67% | -14.42% | -35.97% | |||||||||
| 2025 | 5.03% | -11.98% | -8.84% | -26.01% | 64.40% | 17.18% | -19.37% | 35.06% | -4.33% | -28.14% | 3.50% | -6.08% | -12.58% |
| 2024 | -5.79% | 13.65% | 33.33% | -27.25% | -31.58% | -13.12% | -3.65% | -3.24% | -19.55% | 12.15% | -8.36% | 7.43% | -48.87% |
| 2023 | 25.27% | 10.61% | 0.16% | -9.26% | -29.84% | 4.10% | -0.96% | -25.69% | -2.27% | -32.72% | -36.79% | 21.48% | -65.82% |
| 2022 | -41.23% | 36.48% | -12.90% | -22.39% | 8.93% | -9.88% | 3.58% | -12.91% | 1.64% | -3.05% | -5.95% | -15.35% | -62.33% |
| 2021 | -7.43% | 5.44% | -2.17% | 7.13% | 23.08% | 17.98% | 4.52% | 46.41% | 1.01% | 5.78% | -5.50% | -6.93% | 113.62% |
Benchmark Metrics
The Beauty Health Company has an annualized alpha of -24.04%, beta of 1.81, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since November 25, 2020.
- This stock participated in 215.97% of S&P 500 Index downside but only 23.91% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -24.04%
- Beta
- 1.81
- R²
- 0.12
- Upside Capture
- 23.91%
- Downside Capture
- 215.97%
Return for Risk
Risk / Return Rank
SKIN ranks 29 for risk / return — below 29% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for The Beauty Health Company (SKIN) and compare them to a chosen benchmark (S&P 500 Index).
| SKIN | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.31 | 0.90 | -1.20 |
Sortino ratioReturn per unit of downside risk | 0.24 | 1.39 | -1.15 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.21 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | -0.47 | 1.40 | -1.87 |
Martin ratioReturn relative to average drawdown | -0.86 | 6.61 | -7.47 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore SKIN risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the The Beauty Health Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the The Beauty Health Company was 97.27%, occurring on Mar 27, 2026. The portfolio has not yet recovered.
The current The Beauty Health Company drawdown is 96.98%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.27% | Nov 4, 2021 | 1102 | Mar 27, 2026 | — | — | — |
| -17.42% | Dec 29, 2020 | 77 | Apr 20, 2021 | 9 | May 3, 2021 | 86 |
| -15.86% | Jul 13, 2021 | 11 | Jul 27, 2021 | 11 | Aug 11, 2021 | 22 |
| -13.75% | Sep 7, 2021 | 3 | Sep 9, 2021 | 10 | Sep 23, 2021 | 13 |
| -13.73% | Sep 24, 2021 | 12 | Oct 11, 2021 | 16 | Nov 2, 2021 | 28 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of The Beauty Health Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how The Beauty Health Company is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SKIN relative to other companies in the Household & Personal Products industry. Currently, SKIN has a P/S ratio of 0.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SKIN in comparison with other companies in the Household & Personal Products industry. Currently, SKIN has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |